000 01626 a2200457 4500
005 20250516181005.0
264 0 _c20150715
008 201507s 0 0 eng d
022 _a1460-2091
024 7 _a10.1093/jac/dkt444
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrill, Margreke J E
245 0 0 _aReduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cMar 2014
300 _a715-23 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Intravenous
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aCefazolin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMicrodialysis
650 0 4 _aMiddle Aged
650 0 4 _aModels, Statistical
650 0 4 _aObesity, Morbid
650 0 4 _aPlasma
_xchemistry
650 0 4 _aProspective Studies
650 0 4 _aSubcutaneous Tissue
_xchemistry
700 1 _aHouwink, Aletta P I
700 1 _aSchmidt, Stephan
700 1 _aVan Dongen, Eric P A
700 1 _aHazebroek, Eric J
700 1 _avan Ramshorst, Bert
700 1 _aDeneer, Vera H
700 1 _aMouton, Johan W
700 1 _aKnibbe, Catherijne A J
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 69
_gno. 3
_gp. 715-23
856 4 0 _uhttps://doi.org/10.1093/jac/dkt444
_zAvailable from publisher's website
999 _c23251060
_d23251060